Finasteride Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

OBJECTIVE: In the Prostate Cancer Prevention Trial (PCPT), finasteride reduced the risk of prostate cancer by 25%, even though high-grade prostate cancer was more common in the finasteride group. However, it remains to be determined whether finasteride concentrations may affect prostate cancer risk....

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Chau, Cindy H., Price, Douglas K., Till, Cathee, Goodman, Phyllis J., Chen, Xiaohong, Leach, Robin J., Johnson-Pais, Teresa L., Hsing, Ann W., Hoque, Ashraful, Tangen, Catherine M., Chu, Lisa, Parnes, Howard L., Schenk, Jeannette M., Reichardt, Juergen K. V., Thompson, Ian M., Figg, William D.
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2015
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4425512/
https://ncbi.nlm.nih.gov/pubmed/25955319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0126672
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires